(Q38010200)

26 August 2017

Amino acid metabolism related to immune tolerance by MDSCs (English)

1 reference

26 August 2017

Baohong Yang

1

1 reference

PubMed ID

22587019

26 August 2017

Xiaomeng Wang

series ordinal

2

1 reference

PubMed ID

22587019

26 August 2017

Xiubao Ren

series ordinal

3

1 reference

26 August 2017

1 June 2012

1 reference

International Reviews of Immunology

26 August 2017

1 reference

26 August 2017

31

1 reference

26 August 2017

3

1 reference

26 August 2017

177-183

1 reference

Cancer vaccines: between the idea and the reality

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

GM-CSF-secreting melanoma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Physiological functions of thioredoxin and thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Metabolic mechanisms of cancer-induced inhibition of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

The synthesis of homocystine, cystathionine, and cystine by cultured diploid and heteroploid human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2012.679989

10.3109/08830185.2012.679989

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22587019